Prolocor Inc.
Biotechnology company · Philadelphia, Pennsylvania, United States
Prolocor Inc. is a biotechnology company headquartered in Philadelphia, Pennsylvania, United States. Its earliest recorded incorporation is in 2020. It has reported private securities offerings to the US SEC, most recently $1.6 million sold in a notice filed in 2022.
Prolocor at a glance
What does Prolocor do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $1.6 million sold (2022).
Frequently asked questions about Prolocor
Where is Prolocor headquartered?
Prolocor Inc. is headquartered in Philadelphia, Pennsylvania, United States.
What does Prolocor do?
Prolocor Inc. is a biotechnology company.
When was Prolocor founded?
The earliest incorporation on record for Prolocor Inc. is in 2020, according to public company registers.
Similar companies
- Spark Therapeutics, Inc.Philadelphia, Pennsylvania, United States
- Cabaletta Bio, Inc.Philadelphia, Pennsylvania, United States
- Passage BIO, Inc.Philadelphia, Pennsylvania, United States
- ZSX Medical, LLCPhiladelphia, Pennsylvania, United States
- Enterin, Inc.Philadelphia, Pennsylvania, United States
- Century Therapeutics, Inc.Philadelphia, Pennsylvania, United States
- PolyCore Therapeutics, Inc.Philadelphia, Pennsylvania, United States
- Five Eleven Pharma Inc.Philadelphia, Pennsylvania, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences